Dependence of P2-nucleotide receptor agonist-mediated endothelium-independent relaxation on ectonucleotidase activity and A2A -receptors in rat portal vein
- 1 April 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 123 (8) , 1732-1740
- https://doi.org/10.1038/sj.bjp.0701773
Abstract
1. The mechanism of action of P2 nucleotide receptor agonists that produce endothelium-independent relaxation and the influence of ecto-ATPase activity on this relaxing effect have been investigated in rat portal vein smooth muscle. 2. At 25 degrees C, ATP, 2-methylthioATP (2-MeSATP) and 2-chloroATP (2-ClATP), dose-dependently inhibited spontaneous contractile activity of endothelium-denuded muscular strips from rat portal vein. The rank order of agonist potency defined from the half-inhibitory concentrations was 2-CIATP (2.7+/-0.5 microM, n=7) >ATP (12.9+/-1.1 microM, n=9) > or =2-MeSATP (21.9+/-4.8 M, n=4). In the presence of alphabeta-methylene ATP (alphabeta-MeATP, 200 microM) which itself produced a transient contractile effect, the relaxing action of ATP and 2-MeSATP was completely abolished and that of 2-ClATP strongly inhibited. 3. The non-selective P2-receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, 100 microM) did not affect the relaxation induced by ATP, 2-MeSATP, and 2-ClATP. 4. The A2A-adenosine receptor antagonist ZM 241385 inhibited the ATP-induced relaxation in a concentration-dependent manner (1-100 nM). In the presence of 100 nM ZM 241385, the relaxing effects of 2-MeSATP and 2-ClATP were also inhibited. 5. ADP, AMP and adenosine also produced concentration-dependent inhibition of spontaneous contractions. The relaxing effects of AMP and adenosine were insensitive to alphabeta-MeATP (200 microM) but were inhibited by ZM 241385 (100 nM). 6. Simultaneous measurements of contraction and ecto-ATPase activity estimated by the degradation of [gamma-32P]-ATP showed that muscular strips rapidly (10-60 s) hydrolyzed ATP. This ecto-ATPase activity was abolished in the presence of EDTA and was inhibited by 57+/-11% (n=3) by 200 microM alphabeta-MeATP. 7. These results suggest that ATP and other P2-receptor agonists are relaxant in rat portal vein smooth muscle, because ectonucleotidase activity leads to the formation of adenosine which activates A2A-receptors.Keywords
This publication has 27 references indexed in Scilit:
- Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation?Trends in Pharmacological Sciences, 1997
- Inhibition of Ecto-ATPase by the P2Purinoceptor Agonists, ATPγS, α,β-Methylene-ATP, and AMP-PNP, in Endothelial CellsBiochemical and Biophysical Research Communications, 1997
- Complementary DNA Cloning and Sequencing of the Chicken Muscle Ecto-ATPaseJournal of Biological Chemistry, 1997
- Design and pharmacology of selective P2‐purinoceptor antagonistsJournal of Autonomic Pharmacology, 1996
- Inhibition of ecto‐ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophagesBritish Journal of Pharmacology, 1996
- PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptorsBritish Journal of Pharmacology, 1996
- How should P2x purinoceptors be classified pharmacologically?Trends in Pharmacological Sciences, 1995
- Analysis of P2-Purinoceptor Subtypes on the Smooth Muscle and Endothelium of Rabbit Coronary ArteryJournal of Cardiovascular Pharmacology, 1994
- Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotidesAmerican Journal of Physiology-Cell Physiology, 1993
- Mechanism of contracture on cooling of caffeine‐treated frog skeletal muscle fibres.The Journal of Physiology, 1988